Lista de obras -

A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria.

artículo científico publicado en 2016

Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA GroupA in cooperation with the Austrian ARIA GroupB, the Swiss ARIA GroupC, German Society for Applied A

scientific article published on 28 May 2020

Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c

scientific article published on 08 May 2020

Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c: Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immu

artículo científico publicado en 2020

Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin

artículo científico publicado en 2017

Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF)

artículo científico publicado en 2019

Definition, aims, and implementation of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence

artículo científico publicado en 2020

Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control.

artículo científico publicado en 2014

Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema

scientific article published on 09 December 2019

Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

artículo científico publicado en 2011

High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria

artículo científico publicado en 2011

Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial.

artículo científico publicado en 2017

Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial.

artículo científico publicado en 2017

Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: a randomized, double-blind, placebo-controlled study

article

Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence

artículo científico publicado en 2017

Patients with chronic urticaria exhibit increased rates of sensitisation toCandida albicans, but not to common moulds

scientific article published in 2009

Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria

artículo científico publicado en 2004

Responsiveness and minimal important difference of the urticaria control test.

artículo científico publicado en 2017

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1

scientific article published on 01 August 2019

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2

scientific article published on 01 September 2019

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 1

artículo científico publicado en 2019

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 2

artículo científico publicado en 2019

Severe chronic spontaneous urticaria in children - treatment options according to the guidelines and beyond - a 10 years review

artículo científico publicado en 2020

Substance P is upregulated in the serum of patients with chronic spontaneous urticaria.

artículo científico publicado en 2014

The Urticaria Activity Score-Validity, Reliability, and Responsiveness.

artículo científico publicado en 2017

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

artículo científico publicado en 2020

The response to treatment in chronic spontaneous urticaria depends on how it is measured

scientific article published on 04 February 2019

Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab

scholarly article by Karsten Weller et al published 4 August 2018 in Allergy

Validation of the Angioedema Control Test (AECT)-A Patient-Reported Outcome Instrument for Assessing Angioedema Control

scientific article published on 12 March 2020

Lista de obras de

A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria.

Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA GroupA in cooperation with the Austrian ARIA GroupB, the Swiss ARIA GroupC, German Society for Applied A

Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c

Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c: Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immu

Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin

Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF)

Definition, aims, and implementation of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence

Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control.

Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema

Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria

Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial.

Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial.

Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: a randomized, double-blind, placebo-controlled study

Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence

Patients with chronic urticaria exhibit increased rates of sensitisation toCandida albicans, but not to common moulds

Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria

Responsiveness and minimal important difference of the urticaria control test.

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 1

S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 2

Severe chronic spontaneous urticaria in children - treatment options according to the guidelines and beyond - a 10 years review

Substance P is upregulated in the serum of patients with chronic spontaneous urticaria.

The Urticaria Activity Score-Validity, Reliability, and Responsiveness.

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

The response to treatment in chronic spontaneous urticaria depends on how it is measured

Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab

Validation of the Angioedema Control Test (AECT)-A Patient-Reported Outcome Instrument for Assessing Angioedema Control